Shedding light on the mechanisms that underlie durable response to immunotherapy, a new study evaluating memory T cell responses in long-term melanoma survivors treated with immunotherapy finds that tumor-associated clonotypes are sustained over years and persist as expanded, IFNγ-expressing TRM cells in the skin with TEM counterparts in the blood.